Get startedLog in
    Picture of Valerio Therapeutics SA logo

    ALVIO — Valerio Therapeutics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Onxeo announces allowance of U.S. patent for Livatag in hepatocellular carcinoma

    Picture of Valerio Therapeutics SA logoValerio Therapeutics SA
    10/05/2017 18:06
    May 10 (Reuters) - ONXEO SA  C4X.PA  
    * ONXEO ANNOUNCES ALLOWANCE OF U.S. PATENT FOR LIVATAG IN 
HEPATOCELLULAR CARCINOMA 
    * USPTO NOTICE OF ALLOWANCE RECEIVED FOR PATENT RELATED TO 
SPECIFIC ROUTE OF ADMINISTRATION FOR LIVATAG PROVIDES PROTECTION 
OF RELATED CLAIMS UNTIL 2032 
 
SOURCE TEXT FOR EIKON:  ID:nBw7jvXnXa  
FURTHER COMPANY COVERAGE:  C4X.PA  
 
 (Gdynia Newsroom:) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

    Recent news on Valerio Therapeutics SA

    See all news